Pravigard PAC, the first statin and aspirin combo

August 2003

Bristol-Myers Squibb is now marketing Pravigard PAC, the first statin and aspirin combo.

It's approved to prevent MIs, strokes, and death in patients who already have cardiovascular disease.

But it can also be used in other patients who are candidates for both pravastatin and aspirin.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote